Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2021
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L04AD05
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:drugClass |
immunosuppressant
|
| gptkbp:form |
capsule
|
| gptkbp:genericName |
gptkb:voclosporin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupkynis
|
| gptkbp:indication |
treatment of adult patients with active lupus nephritis
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Aurinia_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
headache hypertension renal impairment |
| gptkbp:usedFor |
lupus nephritis
|
| gptkbp:bfsParent |
gptkb:Aurinia_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|